ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GGAUF Genesis Growth Tech Acquisition Corporation (PK)

8.00
0.00 (0.00%)
28 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Genesis Growth Tech Acquisition Corporation (PK) USOTC:GGAUF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.00 8.00 8.00 0.00 00:00:00

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14/08/2024 11:06am

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2024

 

Commission File Number: 001-41138

 

NEUROMIND AI CORP.

(Exact Name of Registrant as Specified in its Charter)

 

Bahnhofstrasse 3

Hergiswil Nidwalden,Switzerland 6052

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: +41 78 607 99 01

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F

 

 

 

 

 

 

NeuroMind AI Corp. (the “Company”) has determined that it qualifies as a “foreign private issuer” as defined under Rule 3b-4 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Accordingly, by furnishing this current report on Form 6-K, the Company has begun reporting under the Exchange Act as a foreign private issuer. The Company will file its future annual reports on Form 20-F and furnish its future current reports on Form 6-K.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Dated: August 14, 2024    
   
  NEUROMIND AI CORP.
     
  By: /s/ Eyal Perez
  Name: Eyal Perez
  Title: Chief Executive Officer

 

 

2

 

 


1 Year Genesis Growth Tech Acqu... (PK) Chart

1 Year Genesis Growth Tech Acqu... (PK) Chart

1 Month Genesis Growth Tech Acqu... (PK) Chart

1 Month Genesis Growth Tech Acqu... (PK) Chart

Your Recent History